Drug Safety, or Overregulation of Reproductive Health?
Scholar calls for FDA to remove stringent restrictions on medication abortion.
FDA, Not a Federal Judge, Should Decide on Abortion Drugs
Anti-abortion advocates take aim at FDA approval and regulation of the abortion drug mifepristone, threatening access nationwide.
Regulating Supervised Consumption Services
Experts discuss the role of regulations in monitoring experimental overdose prevention programs.
The ADA’s Power to Reduce Overdose Deaths in Prison
Scholars argue that the ADA’s protections could prevent overdose deaths for people in prison.
Hallucinate, Medicate, and Regulate
In this week’s Saturday Seminar, experts discuss ways to regulate psychedelics for medicinal use.
High Hopes for FDA Regulation of CBD Products
FDA regulation of CBD products faces new challenges as the market develops.
Value-Pricing Prescription Drugs
Scholar argues that reducing pricing for prescription drugs may increase innovation.
Pennsylvania Lawmakers Restrict Access to Fentanyl Test Strips
Pennsylvania law prevents people who use drugs from testing for fentanyl and avoiding overdoses.
The Culture of Antibiotics Regulation
Scholars discuss the challenges of promoting antibiotic development and preserving existing drugs.
Regulatory Control of Potentially Addictive Drugs
Scholar explains why the DEA—not FDA—has power over the classification of potentially addictive substances.
Federal Agencies Should Extend Pandemic Flexibilities for Opioid Use Disorder
A new report offers recommendations for extending telehealth treatment of opioid use disorder.
Unlocking Psychedelics’ Medical Potential
Scholars critique the regulation of psychedelic substances and propose reforms for medical research and use.